These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22388168)

  • 1. Atomoxetine for encopresis in 2 children with attention-deficit/hyperactivity disorder.
    Hergüner S; Hergüner A
    J Clin Psychopharmacol; 2012 Apr; 32(2):302-3. PubMed ID: 22388168
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased Frequency of Encopresis in a Child Diagnosed With Attention Deficit/Hyperactivity Disorder and Encopresis After Atomoxetine Use: A Case Report.
    Yektaş Ç; Cansiz MA; Tufan AE
    Clin Neuropharmacol; 2016; 39(4):212-3. PubMed ID: 27332628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Atomoxetine in the Treatment of Children With Encopresis.
    Türkoğlu S; Bilgiç A; Uzun N
    J Clin Psychopharmacol; 2015 Oct; 35(5):622-3. PubMed ID: 26110671
    [No Abstract]   [Full Text] [Related]  

  • 4. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atomoxetine Treatment For Encopresis In A Child With Attention Deficit Hyperactivity Disorder].
    Bozkurt H; Şahin S
    Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27482753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
    Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
    Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial.
    Young JL; Sarkis E; Qiao M; Wietecha L
    Clin Neuropharmacol; 2011; 34(2):51-60. PubMed ID: 21406998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder.
    Takahashi M; Takita Y; Goto T; Ichikawa H; Saito K; Matsumoto H; Tanaka Y
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):55-63. PubMed ID: 21265936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 10. Atomoxetine.
    Unni JC
    Indian Pediatr; 2006 Jul; 43(7):603-6. PubMed ID: 16891679
    [No Abstract]   [Full Text] [Related]  

  • 11. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atomoxetine on cardiovascular functions and on QT dispersion in children with attention deficit hyperactivity disorder.
    Sert A; Gokcen C; Aypar E; Odabas D
    Cardiol Young; 2012 Apr; 22(2):158-61. PubMed ID: 21864451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.
    van der Meer JM; Harfterkamp M; van de Loo-Neus G; Althaus M; de Ruiter SW; Donders AR; de Sonneville LM; Buitelaar JK; Hoekstra PJ; Rommelse NN
    J Clin Psychopharmacol; 2013 Dec; 33(6):824-7. PubMed ID: 24018545
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
    Biederman J; Gao H; Rogers AK; Spencer TJ
    Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atomoxetine (strattera) in the treatment of attention deficit hyperactivity syndrome].
    Ershova A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):87-91. PubMed ID: 19097312
    [No Abstract]   [Full Text] [Related]  

  • 17. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atomoxetine on executive function impairments in adults with ADHD.
    Brown TE; Holdnack J; Saylor K; Adler L; Spencer T; Williams DW; Padival AK; Schuh K; Trzepacz PT; Kelsey D
    J Atten Disord; 2011 Feb; 15(2):130-8. PubMed ID: 20026871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine for attention deficit hyperactivity disorder in mental retardation.
    Fernández-Jaén A; Fernández-Mayoralas DM; Calleja Pérez B; Muñoz Jareño N; Campos Díaz Mdel R
    Pediatr Neurol; 2010 Nov; 43(5):341-7. PubMed ID: 20933178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
    Buitelaar JK; Michelson D; Danckaerts M; Gillberg C; Spencer TJ; Zuddas A; Faries DE; Zhang S; Biederman J
    Biol Psychiatry; 2007 Mar; 61(5):694-9. PubMed ID: 16893523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.